• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    33 Stocks Moving In Friday's Mid-Day Session

    1/7/22 12:12:32 PM ET
    $ABSI
    $AEHR
    $ALGS
    $APCX
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Electrical Products
    Industrials
    Get the next $ABSI alert in real time by email

    Gainers

    • Marin Software Incorporated (NASDAQ:MRIN) shares climbed 35.9% to $4.6899 after the company announced an integration with Amazon Ads' demand-side platform.
    • Absci Corporation (NASDAQ:ABSI) gained 34.4% to $8.25 after the company announced a research collaboration with Merck.
    • OneSmart International Education Group Limited (NYSE:ONE) rose 24.1% to $0.3410 after dipping more than 31% on Thursday.
    • Dogness (International) Corporation (NASDAQ:DOGZ) shares climbed 23.7% to $4.12 after dipping 62% on Thursday.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) shares gained 18.1% to $4.95.
    • Discovery, Inc. (NASDAQ:DISCA) jumped 14.5% to $29.50 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $34 to $45.
    • GameStop Corp. (NYSE:GME) rose 13% to $147.49. GameStop is launching a division to develop an NFT marketplace and launch cryptocurrency partnerships, according to a Wall Street Journal report.
    • Personalis, Inc. (NASDAQ:PSNL) surged 11.8% to $13.47. Personalis said it sees Q4 sales of $20.7 million and FY21 sales of $85.5 million.
    • Tuya Inc. (NYSE:TUYA) jumped 11.4% to $5.48.
    • Nerdy, Inc. (NYSE:NRDY) gained 10.8% to $4.41. Goldman Sachs initiated coverage on Nerdy with a Buy rating and announced a price target of $8.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) gained 10.4% to $2.66.
    • Singular Genomics Systems, Inc. (NASDAQ:OMIC) climbed 9.7% to $9.55. B of A Securities upgraded Singular Genomics Systems from Neutral to Buy and announced a $21 price target.
    • China HGS Real Estate Inc. (NASDAQ:HGSH) jumped 9.7% to $2.4250. Traders may be viewing this stock as a play on a Friday deal by Papa John's to expand its presence in China by 1,350 stores. The Papa John's press release did not specifically mention a real estate company it would be working with for the expansion.
    • Lemonade, Inc. (NYSE:LMND) surged 9.2% to $38.58. Barclays, on Thursday, maintained Lemonade with an Equal-Weight and lowered the price target from $62 to $43.
    • Simulations Plus, Inc. (NASDAQ:SLP) gained 8% to $49.56 following upbeat quarterly sales.
    • WISeKey International Holding AG (NASDAQ:WKEY) rose 6.6% to $4.37 after the company announced plans to generate the first ever NFT from space following the launch of WISeSat on SpaceX Transporter 3 Rideshare mission riding aboard of a Falcon 9 on January 13.

    Check out these big penny stock gainers and losers

    Losers

    • Siyata Mobile Inc. (NASDAQ:SYTA) shares dipped 43.7% to $1.82 after the company announced pricing of a $20 million underwritten public offering.
    • Zhangmen Education Inc. (NYSE:ZME) shares dropped 19.3% to $1.9201.
    • Nuverra Environmental Solutions, Inc. (NYSE:NES) fell 17% to $1.82.
    • Aehr Test Systems (NASDAQ:AEHR) dropped 14.5% to $17.50 after reporting Q2 results.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) fell 14.1% to $2.25. DBGI said it sees Q4 revenue in line with prior forecast of $4 million. The company also expects fiscal year 2021 net revenue to increase 44% to $7.6 million.
    • Alterity Therapeutics Limited (NASDAQ:ATHE) shares fell 14.1% to $0.9530. Alterity Therapeutics shares jumped around 34% on Thursday after the company announced it was granted a new US patent for "Compounds for and Methods of Treating Diseases."
    • Kura Sushi USA, Inc. (NASDAQ:KRUS) dropped 13.7% to $60.37 after reporting downbeat quarterly sales.
    • Heliogen, Inc. (NYSE:HLGN) dropped 10.8% to $7.03.
    • Sunlight Financial Holdings Inc. (NYSE:SUNL) fell 10.5% to $3.8450.
    • The New York Times Company (NYSE:NYT) fell 10.3% to $42.89 after the company announced it will acquire The Athletic for $550 million.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 9.9% to $1.19. Plus Therapeutics recently entered into an agreement with UT Health San Antonio for a worldwide exclusive license to develop and commercialize novel interventional therapeutics for cancer.
    • Phunware, Inc. (NASDAQ:PHUN) dropped 9.8% to $2.7701.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) dipped 9.4% to $54.62. A Thursday afternoon Reuters report suggested Digital World special purpose acquisition corporation (SPAC) merger partner, Trump Media Group, could launch its social media app in February.
    • Aligos Therapeutics, Inc. (NASDAQ:ALGS) dipped 9% to $4.1750. JP Morgan downgraded Aligos Therapeutics from Overweight to Neutral and lowered the price target from $30 to $12.
    • Cytokinetics, Incorporated (NASDAQ:CYTK) fell 8.5% to $35.49. Cytokinetics and Royalty Pharma report funding deals for total of up to $450 million.
    • China Natural Resources, Inc. (NASDAQ:CHNR) shares fell 7% to $0.80 after jumping around 28% on Thursday.
    • AppTech Payments Corp. (NASDAQ:APCX) fell 6.4% to $2.34 after gaining 8% on Thursday.
    Get the next $ABSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABSI
    $AEHR
    $ALGS
    $APCX

    CompanyDatePrice TargetRatingAnalyst
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Cytokinetics Incorporated
    $CYTK
    1/28/2026$87.00Overweight
    Barclays
    Absci Corporation
    $ABSI
    1/8/2026$4.32Overweight → Equal-Weight
    Morgan Stanley
    Lemonade Inc.
    $LMND
    1/6/2026$98.00Buy
    Truist
    Simulations Plus Inc.
    $SLP
    12/18/2025Buy → Neutral
    BTIG Research
    Cytokinetics Incorporated
    $CYTK
    12/18/2025$95.00Neutral → Buy
    Goldman
    Aehr Test Systems
    $AEHR
    12/17/2025$29.00Buy
    Lake Street
    Lemonade Inc.
    $LMND
    12/16/2025$85.00Underweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ABSI
    $AEHR
    $ALGS
    $APCX
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Kura Sushi USA Inc.

    SCHEDULE 13G - KURA SUSHI USA, INC. (0001772177) (Subject)

    2/6/26 5:21:21 PM ET
    $KRUS
    Restaurants
    Consumer Discretionary

    SEC Form DEFA14A filed by Simulations Plus Inc.

    DEFA14A - Simulations Plus, Inc. (0001023459) (Filer)

    2/4/26 4:10:05 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form 8-K filed by Aligos Therapeutics Inc.

    8-K - Aligos Therapeutics, Inc. (0001799448) (Filer)

    2/4/26 4:05:42 PM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABSI
    $AEHR
    $ALGS
    $APCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nerdy to Announce Fourth Quarter and Full Year 2025 Results on February 26, 2026

    Nerdy Inc. (NYSE:NRDY), a leading platform for delivering live online learning, today announced the Company will release its fourth quarter and full year financial results for the period ended December 31, 2025 after the U.S. stock market closes on Thursday, February 26, 2026. Following the release, Nerdy management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial and operating results. Interested parties in the U.S. may listen to the call by dialing 1-833-470-1428. International callers can dial 1-404-975-4839. The Access Code is 541162. A live webcast of the call will also be available on Nerdy's investor relations website at https://w

    2/5/26 4:01:00 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    WISeKey, WISeSat and Latitude Join Forces to Prepare a Future Secure IoT Satellite Constellation

      Geneva, Switzerland  / Reims, February 5, 2026 – WISeKey International Holding Ltd ("WISeKey") ((SIX: WIHN, NASDAQ:WKEY), a leading global cybersecurity, blockchain, and IoT company, its subsidiary WISeSat.Space AG  ("WISeSat") which focuses on space technology for secure satellite communication, specifically for IoT applications, and Latitude, a French aerospace company designing, manufacturing and operating an orbital launch vehicle, today announced the signing of a commercial agreement to assess the orbital launch of WISeSat's planned secure IoT satellite constellation. This agreement represents another step forward in WISeSat's strategy which aims at deploying 100 satellites by 2029,

    2/5/26 1:00:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    The New York Times Company Reports Fourth-Quarter and Full-Year 2025 Results

    The New York Times Company (NYSE:NYT) announced today that its fourth-quarter and full-year 2025 financial results are available on The New York Times Company's investor relations website at investors.nytco.com. As previously announced, The New York Times Company will host its earnings conference call today at 8:00 a.m. E.T. to discuss these results. A live webcast of the earnings conference call will be available at investors.nytco.com. Participants can pre-register for the telephone conference at https://dpregister.com/sreg/10206007/10324520f92, which will generate dial-in instructions allowing participants to bypass an operator at the time of the call. Alternatively, to access the call

    2/4/26 7:02:00 AM ET
    $NYT
    Newspapers/Magazines
    Consumer Discretionary

    $ABSI
    $AEHR
    $ALGS
    $APCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Commercial Officer Callos Andrew exercised 15,000 shares at a strike of $23.26 and sold $928,950 worth of shares (15,000 units at $61.93) (SEC Form 4)

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    2/5/26 8:17:30 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Schreiber Daniel A. sold $902,056 worth of shares (9,108 units at $99.04) (SEC Form 4)

    4 - Lemonade, Inc. (0001691421) (Issuer)

    2/4/26 9:15:01 PM ET
    $LMND
    Property-Casualty Insurers
    Finance

    Director Slayen Howard T gifted 15,000 shares, decreasing direct ownership by 7% to 203,328 units (SEC Form 4)

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    2/4/26 8:34:46 PM ET
    $AEHR
    Electrical Products
    Industrials

    $ABSI
    $AEHR
    $ALGS
    $APCX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Plus Therapeutics with a new price target

    Lake Street initiated coverage of Plus Therapeutics with a rating of Buy and set a new price target of $2.00

    2/3/26 8:52:26 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Barclays resumed coverage on Cytokinetics with a new price target

    Barclays resumed coverage of Cytokinetics with a rating of Overweight and set a new price target of $87.00

    1/28/26 7:16:37 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Absci Corporation downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Absci Corporation from Overweight to Equal-Weight and set a new price target of $4.32

    1/8/26 8:35:39 AM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ABSI
    $AEHR
    $ALGS
    $APCX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ABSI
    $AEHR
    $ALGS
    $APCX
    Leadership Updates

    Live Leadership Updates

    View All

    Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

    − Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced − Highlights Phase 2 data for ATH434 in Multiple System Atrophy (MSA) strengthened by additional analyses and multiple international scientific presentations during the quarter.Regulatory planning activities advancing toward a pivotal Phase 3 program, including preparation for FDA End-Of-Phase-2 meeting in mid-2026.Ongoing partnering and strategic discussions with pharmaceutical companies and corporate advisers to explore non-dilutive pathways to fund Phase 3 development.Board and executive leadership strengthened to support Alterity through its next stage of clinical development, partnering and comme

    1/30/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)

    "On Track with HCM" Features Practical Insights for Managing Everyday Life with the Disease, Inspired by the Experience with HCM of McLaughlin-Levrone's Father, Willie McLaughlin SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced the launch of "On Track with HCM," demonstrating the company's long-standing commitment to the HCM community. The campaign features four-time Olympic gold medalist Sydney McLaughlin-Levrone, and her father, three-time all-American track star, Willie McLaughlin, who suffered from the non-obstructive form of hypertrophic cardiomyopathy (HCM) for more than two decades before receiving a heart trans

    1/27/26 8:00:00 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kura Sushi USA Announces Election of Claudia Schaefer to the Company's Board of Directors

    IRVINE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company"), (NASDAQ:KRUS), a technology-enabled Japanese restaurant concept, today announced that Claudia Schaefer has been elected to serve as an independent member of the Board of Directors effective January 21, 2026. In conjunction with Ms. Schaefer's nomination, Kim Ellis did not stand for re-election as a director, also effective January 21, 2026. Hajime Uba, President, Chief Executive Officer and Chairman of Kura Sushi, stated, "We are thrilled to announce the election of Claudia to Kura Sushi USA's Board of Directors. Claudia's deep brand and marketing background makes her an excellent addit

    1/22/26 4:05:00 PM ET
    $KRUS
    Restaurants
    Consumer Discretionary

    $ABSI
    $AEHR
    $ALGS
    $APCX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nerdy Inc.

    SC 13D/A - Nerdy Inc. (0001819404) (Subject)

    12/4/24 4:01:10 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Singular Genomics Systems Inc.

    SC 13D/A - Singular Genomics Systems, Inc. (0001850906) (Subject)

    11/22/24 7:55:51 PM ET
    $OMIC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Siyata Mobile Inc.

    SC 13G/A - Siyata Mobile Inc. (0001649009) (Subject)

    11/14/24 7:28:44 PM ET
    $SYTA
    Telecommunications Equipment
    Telecommunications

    $ABSI
    $AEHR
    $ALGS
    $APCX
    Financials

    Live finance-specific insights

    View All

    Nerdy to Announce Fourth Quarter and Full Year 2025 Results on February 26, 2026

    Nerdy Inc. (NYSE:NRDY), a leading platform for delivering live online learning, today announced the Company will release its fourth quarter and full year financial results for the period ended December 31, 2025 after the U.S. stock market closes on Thursday, February 26, 2026. Following the release, Nerdy management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial and operating results. Interested parties in the U.S. may listen to the call by dialing 1-833-470-1428. International callers can dial 1-404-975-4839. The Access Code is 541162. A live webcast of the call will also be available on Nerdy's investor relations website at https://w

    2/5/26 4:01:00 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    The New York Times Company Reports Fourth-Quarter and Full-Year 2025 Results

    The New York Times Company (NYSE:NYT) announced today that its fourth-quarter and full-year 2025 financial results are available on The New York Times Company's investor relations website at investors.nytco.com. As previously announced, The New York Times Company will host its earnings conference call today at 8:00 a.m. E.T. to discuss these results. A live webcast of the earnings conference call will be available at investors.nytco.com. Participants can pre-register for the telephone conference at https://dpregister.com/sreg/10206007/10324520f92, which will generate dial-in instructions allowing participants to bypass an operator at the time of the call. Alternatively, to access the call

    2/4/26 7:02:00 AM ET
    $NYT
    Newspapers/Magazines
    Consumer Discretionary

    Lemonade To Announce Fourth Quarter 2025 Financial Results

    Lemonade (NYSE:LMND) today announced it will release its fourth quarter 2025 financial results on Thursday, February 19, 2026 prior to market open, and will host a conference call that same day to discuss the results. Webcast and Conference Call details: Date: February 19, 2026 Time: 8:00 am Eastern time (5:00 am Pacific time) Participant Toll-Free Dial-In Number: +1 833 470 1428 Participant Toll Dial-In Number: +1 646 844 6383 Access Code: 066044 Conference call registration link Webcast registration link Following the completion of the call, a replay will also be made available at lemonade.com/investor. In addition to the dial-in options, shareholders can parti

    1/27/26 8:22:00 AM ET
    $LMND
    Property-Casualty Insurers
    Finance

    $ABSI
    $AEHR
    $ALGS
    $APCX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care